REAL WORLD EFFECTIVENESS OF IVACAFTOR IN PEDIATRIC CYSTIC FIBROSIS PATIENTS

被引:0
|
作者
Greenawald, L. [1 ]
Shenoy, A. [1 ]
Elidemir, O. [2 ]
Livingston, F. [3 ]
Schaeffer, D. [4 ]
Chidekel, A. [1 ]
机构
[1] AI duPont Nemours Childrens Hosp, Pediat Pulm, Alburtis, PA USA
[2] Nemours Childrens Hosp, Pediat Pulm, Pensacola, FL USA
[3] Nemours Childrens Hosp, Pediat Pulm, Orlando, FL USA
[4] Nemours Childrens Hosp, Pediat Pulm, Jacksonville, FL USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
26
引用
收藏
页码:157 / 157
页数:1
相关论文
共 50 条
  • [1] Real-World Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Triple Combination Therapy in Pediatric Patients with Cystic Fibrosis
    Nazzari, E.
    Russo, M.
    Faelli, N.
    Rosazza, C.
    Bricchi, S.
    Rizza, C.
    Alicandro, G.
    Dacco, V
    PEDIATRIC PULMONOLOGY, 2023, 58 : S115 - S115
  • [2] REAL WORLD MULTICENTER EXPERIENCE OF PEDIATRIC CYSTIC FIBROSIS PATIENTS STARTED ON TEZACAFTOR/IVACAFTOR plus IVACAFTOR
    Pan, A.
    Autry, E.
    McKinzie, C. J.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S335 - S335
  • [3] Real World Respiratory Effectiveness of Lumacaftor-Ivacaftor in Children with Cystic Fibrosis at Four Nemours Cystic Fibrosis Centers
    Greenawald, L.
    Shenoy, A. R.
    Peeke, K.
    Elidemir, O.
    Livingston, F. R.
    Schaeffer, D. A.
    Chidekel, A. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [4] SAFETY AND REAL WORLD NUTRITIONAL EFFECTIVENESS OF LUMACAFTOR-IVACAFTOR IN CHILDREN WITH CYSTIC FIBROSIS AT FOUR NEMOURS CYSTIC FIBROSIS CENTERS
    Greenawald, L.
    Shenoy, A.
    Peeke, K.
    Elidemir, O.
    Livingston, F.
    Schaeffer, D.
    Chidekel, A.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S318 - S318
  • [5] Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis
    Burgel, Pierre-Regis
    Munck, Anne
    Durieu, Isabelle
    Chiron, Raphael
    Mely, Laurent
    Prevotat, Anne
    Murris-Espin, Marlene
    Porzio, Michele
    Abely, Michel
    Reix, Philippe
    Marguet, Christophe
    Macey, Julie
    Sermet-Gaudelus, Isabelle
    Corvol, Harriet
    Bui, Stephanie
    Lemonnier, Lydie
    Dehillotte, Clemence
    Da Silva, Jennifer
    Paillasseur, Jean-Louis
    Hubert, Dominique
    Mounard, Julie
    Poulet, Claire
    Rames, Cinthia
    Person, Christine
    Troussier, Francoise
    Urban, Thierry
    Dalphin, Marie-Laure
    Dalphin, Jean-Claude
    Pernet, Didier
    Richaud-Thiriez, Benedicte
    Fayon, Mickael
    Macey-Caro, Julie
    Campbell, Karine
    Laurans, Muriel
    Borderon, Corinne
    Heraud, Marie-Christine
    Labbe, Andre
    Montcouquiol, Sylvie
    Bassinet, Laurence
    Remus, Natascha
    Fanton, Annlyse
    Houzel-Charavel, Anne
    Huet, Frederic
    Perez-Martin, Stephanie
    Boldron-Ghaddar, Amale
    Scalbert, Manuela
    Camara, Boubou
    Llerena, Catherine
    Pin, Isabelle
    Quetant, Sebastien
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (02) : 188 - 197
  • [6] Real World Assessment of Patients with Cystic Fibrosis Treated with Lumacaftor-Ivacaftor and Transitioned to Tezacaftor-Ivacaftor
    Christmas, A.
    O'Hagan, A. R.
    Morton, R. L.
    Eid, N. S.
    Bickel, S. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [7] Real-world effectiveness of ivacaftor in children with cystic fibrosis and the G551D mutation
    Gomez-Pastrana, David
    Nwokoro, Chinedu
    McLean, Mike
    Brown, Sarah
    Christiansen, Nanna
    Pao, Caroline S.
    ANALES DE PEDIATRIA, 2019, 90 (03): : 148 - 156
  • [8] Real-world effectiveness of elexacaftor/tezacaftor/ivacaftor on the burden of illness in adolescents and adults with cystic fibrosis
    Keens, Thomas
    Hoffman, Veena
    Topuria, Ia
    Elder, Ken
    Cerf, Shannon
    Mulder, Kyra
    Roberts, Jon
    Lysinger, Jerimiah
    Del Carmen Reyes, Maria
    Berdella, Maria
    Cairns, Anne Marie
    Jain, Manu
    Ganapathy, Vaidyanathan
    Lou, Yiyue
    Morcos, Bassem
    Wu, Chuntao
    Sass, Laura
    HELIYON, 2024, 10 (07)
  • [9] SAFETY AND EFFICACY OF LUMACAFTOR/IVACAFTOR IN PEDIATRIC CYSTIC FIBROSIS PATIENTS
    Wainwright, C.
    Chilvers, M.
    Hug, C.
    Marigowda, G.
    Tian, S.
    Solomon, M.
    Black, P.
    Rosenfeld, M.
    Sawicki, G.
    Hoppe, J.
    RESPIROLOGY, 2018, 23 : 141 - 141
  • [10] CT Imaging of Pediatric Patients with Cystic Fibrosis on Ivacaftor Therapy
    Hayes, Don, Jr.
    Long, Frederick R.
    McCoy, Karen S.
    Sheikh, Shahid I.
    LUNG, 2014, 192 (05) : 823 - 824